Trial start always bumps share price. And I’d say an interim readout could really increase the price if good and media grabs on. We are going to move into Oct Nov which brings many of the US states indoors and flu season. So it could get interesting again
“ per my call with the ceo a few weeks back, we should be hearing mid-september on grant(s). he is basing it on the current 2-3 month turnaround time.” What!? The ceo said mid September? Someone should tell the good doctor!